3 Followers on Owler
OverviewCompetitorsFundingNews & Insights

PABC Competitors or Alternatives

PABC's top competitors include MSK, Tanabe Research and JAX.

Unlock 12 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

PABC's company profile

Louis P. Kassa

President & CEO

90/100
100 - 250
$5M
$5M - 25M
  • $5M
    $5M - 25M
  • 100 - 250
    $5M
  • $5M - 25M
  • 90/100
  • 100 - 250
  • $5M
  • $5M - 25M
View ProfileView
1
PABC's Competitor - MSK logo

Selwyn Vickers

President & CEO

74/100
21,077
- -
$7.4B
  • - -
    $7.4B
  • 21,077
    - -
  • $7.4B
  • 74/100
  • 21,077
  • - -
  • $7.4B
View ProfileView
2
PABC's Competitor - Tanabe Research logo

CEO

- -
- -
  • - -
  • - -
  • - -
  • - -
View ProfileView
3
PABC's Competitor - JAX logo

Lon Cardon

President & CEO

83/100
3,185
- -
$587.7M
  • - -
    $587.7M
  • 3,185
    - -
  • $587.7M
  • 83/100
  • 3,185
  • - -
  • $587.7M
View ProfileView
4
PABC's Competitor - Ability Pharma logo

Carles Domenech

Co-Founder & CEO

86/100
25 - 100
$25.5M
$5M - 25M
  • $25.5M
    $5M - 25M
  • 25 - 100
    $25.5M
  • $5M - 25M
  • 86/100
  • 25 - 100
  • $25.5M
  • $5M - 25M
View ProfileView
5
PABC's Competitor - Abbott logo

Robert B. Ford

Chairman & CEO

82/100
115,000
$6.9M
$42B
  • $6.9M
    $42B
  • 115,000
    $6.9M
  • $42B
  • 82/100
  • 115,000
  • $6.9M
  • $42B
View ProfileView
PABC's top 15 competitors are MSK, Tanabe Research, JAX, AltMed, Ability Pharma, Abbott, Cipla, Bristol-Myers Squibb, Trustpilot, Cambium Networks, GSK, Pfizer, Merck, Johnson & Johnson and AbbVie. Together they have raised over 41.2B between their estimated 641.2K employees. PABC's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 27.7B. PABC has 100 employees and is ranked 14th among it's top 10 competitors. The top 10 competitors average 42,755.

PABC VS MSK

MSK is PABC's top competitor. MSK was founded in 1884 in New York, New York. MSK competes in the Hospitals field. MSK generates $7.3B more revenue than PABC.

PABC VS JAX

JAX is one of PABC's top competitors. JAX is a NGO/NPO/NFP/Organization/Association company that was founded in Bar Harbor, Maine in 1929. Like PABC, JAX also competes in the Non-Profit Organization field. JAX has 3,085 more employees vs. PABC.

Looking for similar companies to PABC?

Similar Companies

Pharmaceuticals companies in Doylestown

See 14 companies 
Companies in Doylestown with employees in 100-250 range

See 43 companies 
Pharmaceuticals & Biotechnology companies in Doylestown

See 26 companies 
Biotechnology companies in Doylestown

See 18 companies 
Non-Profit Organization companies in Doylestown

See 58 companies 
Non-Profit & Government companies in Doylestown

See 102 companies 
Biotechnology companies in Delaware Valley

See 393 companies 
Pharmaceuticals companies in Delaware Valley

See 442 companies 
Biotechnology companies in Pennsylvania

See 442 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for PABC and PABC's Competitors

April 28, 2025StreetInsider
New England Journal of Medicine Study Led by Memorial Sloan Kettering Cancer Center Demonstrates That Immunotherapy......
April 28, 2025Applied Clinical Trials
In the pivotal CREST clinical trial, sasanlimab in combination with Bacillus Calmette-Guérin met the primary endpoint of event-free survival....
Today 6:38 AMPharmabiz
Merck, known as MSD outside of the United States and Canada, announced results from the phase 3 KEYNOTE─689 trial evaluating Keytruda (pembrolizumab), ...
April 28, 2025Nasdaq
(RTTNews) - Abbott (ABT) announced data from the AVEIR Conduction System Pacing acute clinical feasibility study, which demonstrated the safety and per...
Today 2:02 PMApplied Clinical Trials
Early findings from Johnson & Johnson's Phase IIb SunRISe-1 trial show the promise of TAR-200 in patients with Bacillus Calmette-Guérin-unresponsive, h...
April 27, 2025Business Standard
The US already contributes a significant share, around a quarter, of Cipla's total revenues...
April 28, 2025Zacks
We expect GSK's specialty products like Cabenuva, Juluca, Dovato, Nucala, Ojjaara, Jemperli and Trelegy Ellipta to have driven first-quarter sales perf...
Today 12:27 PMSeeking Alpha
Today 12:12 PMStreetInsider
     RINVOQ (upadacitinib) is now the first and only oral Janus Kinase (JAK) inhibitor approved for the treatment of GCA in adults     Also k...
Today 10:44 AMMedical Device Network
The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device. The post FDA grants breakt...

Frequently Asked Questions about PABC

  1. Who are PABC's top competitors?

    PABC's top 3 competitors are MSK, Tanabe Research, JAX.

  2. Who is similar to PABC?

    MSK is the most similar to PABC. Tanabe Research and JAX are also similar to PABC.

  1. Are PABC and MSK competitors?

    Yes, MSK is one of PABC’s top competitors.